bezafibrate | 			
41859-67-0 | 
				
Bezalip | 			
Cedur | 
				
Bezafibrat | 			
Befizal | 
				
Sklerofibrat | 			
Azufibrat | 
				
Bezatol | 			
Bezafibratum | 
				
Bezafibrato | 			
Bezafibratum INN-Latin | 
				
Bezafibrato INN-Spanish | 			
Bezatol SR (TN) | 
				
BM-15.075 | 			
2-4-2-(4-chlorobenzoyl)aminoethylphenoxy-2-methylpropanoic acid | 
				
UNII-Y9449Q51XH | 			
Difaterol | 
				
2-(p-(2-(p-Chlorobenzamido)ethyl)phenoxy)-2-methylpropionic acid | 			
BM 15.075 | 
				
BM15075 | 			
BM-15075 | 
				
MLS000028533 | 			
CHEMBL264374 | 
				
durabezur | 			
Reducterol | 
				
Bezabeta | 			
Bezacur | 
				
Bezamerck | 			
Eulitop | 
				
Solibay | 			
CHEBI:47612 | 
				
Lipox | 			
2-4-2-(4-Chlorobenzamido)ethylphenoxy-2-methylpropanoic acid | 
				
Bezafibrat PB | 			
Y9449Q51XH | 
				
Beza-Lande | 			
Beza-Puren | 
				
Regadrin B | 			
2-4-2-(4-chlorobenzoyl)aminoethylphenoxy-2-methyl-propanoic acid | 
				
Propanoic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl- | 			
Propanoic acid, 2-4-2-(4-chlorobenzoyl)aminoethylphenoxy-2-methyl- | 
				
MFCD00078970 | 			
NCGC00016850-01 | 
				
SMR000058298 | 			
Bezafibrato Spanish | 
				
Bezalip Retard | 			
CAS-41859-67-0 | 
				
DSSTox_CID_9869 | 			
Propionic acid, 2-(4-(2-((4-chlorobenzoyl)amino)ethyl)phenoxy)-2-methyl- | 
				
DSSTox_RID_78826 | 			
DSSTox_GSID_29869 | 
				
2-(4-(2-(4-Chlorobenzamido)ethyl)phenoxy)-2-methylpropanoic acid | 			
2-{4-2-(4-chlorobenzamido)ethylphenoxy}-2-methylpropanoic acid | 
				
LO 44 | 			
2-(4-{2-(4-chlorobenzoyl)aminoethyl}phenoxy)-2-methylpropanoic acid | 
				
2-(4-{2-(4-chlorophenyl)formamidoethyl}phenoxy)-2-methylpropanoic acid | 			
2-P-2-P-CHLOROBENZAMIDO)ETHYLPHENOXY-2-METHYLPROPIONIC ACID | 
				
BF-759 | 			
CCRIS 9085 | 
				
BM 15075 | 			
SR-01000000106 | 
				
EINECS 255-567-9 | 			
BRN 4267656 | 
				
Bezalip SR | 			
Bezafibrate,(S) | 
				
Bezafibrate USAN:INN:BAN:JAN | 			
PEM | 
				
Prestwick_724 | 			
BENAFIBRATE | 
				
Spectrum_001443 | 			
Opera_ID_376 | 
				
Prestwick0_000378 | 			
Prestwick1_000378 | 
				
Prestwick2_000378 | 			
Prestwick3_000378 | 
				
Spectrum2_000922 | 			
Spectrum3_001500 | 
				
Spectrum4_000325 | 			
Spectrum5_001079 | 
				
Spectrum5_001967 | 			
SCHEMBL16299 | 
				
Bezafibrate-d6(dimethyl-d6) | 			
BSPBio_000535 | 
				
BSPBio_001314 | 			
BSPBio_003119 | 
				
KBioGR_000034 | 			
KBioGR_000669 | 
				
KBioSS_000034 | 			
KBioSS_001923 | 
				
MLS001148205 | 			
Bezafibrate, >=98%, solid | 
				
DivK1c_000092 | 			
SPECTRUM1502046 | 
				
SPBio_000824 | 			
SPBio_002456 | 
				
BPBio1_000589 | 			
GTPL2668 | 
				
DTXSID3029869 | 			
BDBM28701 | 
				
Bezafibrate (JP17/USAN/INN) | 			
HMS500E14 | 
				
KBio1_000092 | 			
KBio2_000034 | 
				
KBio2_001923 | 			
KBio2_002602 | 
				
KBio2_004491 | 			
KBio2_005170 | 
				
KBio2_007059 | 			
KBio3_000067 | 
				
KBio3_000068 | 			
KBio3_002619 | 
				
2-4-2-(4-Chlorobenzamido)ethylphenoxyisobutyric Acid | 			
NINDS_000092 | 
				
Bio2_000034 | 			
Bio2_000514 | 
				
HMS1361B16 | 			
HMS1569K17 | 
				
HMS1791B16 | 			
HMS1921H16 | 
				
HMS1989B16 | 			
HMS2089F04 | 
				
HMS2092B12 | 			
HMS2096K17 | 
				
HMS2233E22 | 			
HMS3261D21 | 
				
HMS3369B13 | 			
HMS3402B16 | 
				
HMS3650K22 | 			
HMS3652M22 | 
				
HMS3713K17 | 			
Pharmakon1600-01502046 | 
				
BCP03700 | 			
HY-B0637 | 
				
ZINC3956919 | 			
Tox21_110645 | 
				
Tox21_301845 | 			
Tox21_500500 | 
				
CCG-39683 | 			
NSC758174 | 
				
s4159 | 			
AKOS005107743 | 
				
Tox21_110645_1 | 			
AB03023 | 
				
AC-6817 | 			
BCP9000398 | 
				
DB01393 | 			
HS-0040 | 
				
LP00500 | 			
MCULE-9775992840 | 
				
NSC 758174 | 			
NSC-758174 | 
				
SB17361 | 			
SDCCGSBI-0051715.P003 | 
				
VA10400 | 			
IDI1_000092 | 
				
IDI1_033784 | 			
NCGC00016850-02 | 
				
NCGC00016850-03 | 			
NCGC00016850-04 | 
				
NCGC00016850-05 | 			
NCGC00016850-06 | 
				
NCGC00016850-07 | 			
NCGC00016850-08 | 
				
NCGC00016850-09 | 			
NCGC00016850-10 | 
				
NCGC00016850-11 | 			
NCGC00016850-12 | 
				
NCGC00016850-15 | 			
NCGC00016850-25 | 
				
NCGC00023317-03 | 			
NCGC00023317-04 | 
				
NCGC00023317-05 | 			
NCGC00023317-06 | 
				
NCGC00023317-07 | 			
NCGC00023317-08 | 
				
NCGC00255376-01 | 			
NCGC00261185-01 | 
				
BB166159 | 			
Bezafibrate, analytical reference material | 
				
BCP0726000153 | 			
Bezafibrate 100 microg/mL in Acetonitrile | 
				
SBI-0051715.P002 | 			
2-(4-(2-(4-chlorobenzamido)ethyl)phenoxy) | 
				
AB00052265 | 			
B3346 | 
				
FT-0622617 | 			
ST51014927 | 
				
SW196871-4 | 			
D01366 | 
				
D70191 | 			
AB00052265-15 | 
				
AB00052265_16 | 			
AB00052265_17 | 
				
859B670 | 			
Q577387 | 
				
SR-01000000106-3 | 			
SR-01000000106-4 | 
				
SR-01000000106-5 | 			
W-106291 | 
				
BRD-K46018455-001-06-0 | 			
BRD-K46018455-001-17-7 | 
				
SR-01000000106-10 | 			
Bezafibrate, European Pharmacopoeia (EP) Reference Standard | 
				
2-(4-(2-parachlorobenzamidoethyl)phenoxy)-2-methylpropionic acid | 			
2-4-2-(4-chlorobezamide)ethylphenoxy-2-methylpropanoic acid | 
				
2-(4-{2-(4-chlorophenyl)carbonylaminoethyl}phenoxy)-2-methylpropanoic acid | 			
2-4-(2-{(4-chlorophenyl)carbonylamino}ethyl)phenoxy-2-methylpropanoic acid | 
				
BF; 2-4-2-(4-chlorobenzoyl)aminoethylphenoxy-2-methyl propanoic acid | 			
 |